Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 830.55 | 1856.00 | 1997.25 | 0.9293 | 0.8874 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 856.00 | 1997.25 | 0.4286 | 0.0241 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 830.55 | 751.00 | 1997.25 | 0.3760 | -0.0765 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1778.00 | 1997.25 | 0.8902 | 0.8245 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1546.00 | 1997.25 | 0.7741 | 0.6337 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 1250.00 | 830.55 | 1561.00 | 1997.25 | 0.7816 | 0.6462 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 1784.00 | 1997.25 | 0.8932 | 0.8293 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1933.00 | 1997.25 | 0.9678 | 0.9490 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1154.00 | 1997.25 | 0.5778 | 0.2967 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2135.00 | 1997.25 | 1.0690 | 1.1082 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 1250.00 | 830.55 | 943.00 | 1997.25 | 0.4722 | 0.1055 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1414.00 | 1997.25 | 0.7080 | 0.5225 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 830.55 | 1692.00 | 1997.25 | 0.8472 | 0.7544 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 2390.00 | 1997.25 | 1.1966 | 1.3047 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 2065.00 | 1997.25 | 1.0339 | 1.0534 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 830.55 | 2095.00 | 1997.25 | 1.0489 | 1.0769 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 830.55 | 1132.00 | 1997.25 | 0.5668 | 0.2771 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 1250.00 | 830.55 | 1520.00 | 1997.25 | 0.7611 | 0.6119 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2049.00 | 1997.25 | 1.0259 | 1.0408 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 1250.00 | 830.55 | 837.00 | 1997.25 | 0.4191 | 0.0061 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 1250.00 | 830.55 | 714.00 | 1997.25 | 0.3575 | -0.1126 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 1752.00 | 1997.25 | 0.8772 | 0.8034 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 2060.00 | 1997.25 | 1.0314 | 1.0495 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 1416.00 | 1997.25 | 0.7090 | 0.5242 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 830.55 | 956.00 | 1997.25 | 0.4787 | 0.1175 |